Morgan Stanley’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.24K | Buy |
|
|||||
|
2025
Q1 | $10.4K | Buy |
|
|||||
|
2024
Q4 | $9.63K | Sell |
|
|||||
|
2024
Q3 | $38.3K | Sell |
|
|||||
|
2024
Q2 | $50.6K | Sell |
|
|||||
|
2024
Q1 | $267K | Sell |
|
|||||
|
2023
Q4 | $697K | Buy |
|
|||||
|
2023
Q3 | $1.19M | Buy |
|
|||||
|
2023
Q2 | $926K | Buy |
|
|||||
|
2023
Q1 | $736K | Sell |
|
|||||
|
2022
Q4 | $1.16M | Sell |
|
|||||
|
2022
Q3 | $3.17M | Buy |
|
|||||
|
2022
Q2 | $551K | Buy |
|
|||||
|
2022
Q1 | $622K | Buy |
|
|||||
|
2021
Q4 | $632K | Sell |
|
|||||
|
2021
Q3 | $1.36M | Buy |
|
|||||
|
2021
Q2 | $914K | Sell |
|
|||||
|
2021
Q1 | $1.71M | Buy |
|
|||||
|
2020
Q4 | $1.7M | Buy |
|
|||||
|
2020
Q3 | $120K | Buy |
|